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Antisens Protein of HTLV-2 (APH-2) was described in
2009. APH-2 mRNA is expressed in vivo in most HTLV-2
carriers. In recent years, several laboratories have searched
for similarities and/or differences between APH-2 and the
antisens protein of HTLV-1, HBZ. Similarly to HBZ,
APH-2 negatively regulates HTLV-2 transcription. How-
ever, it does not promote cell proliferation. In vivo, APH-2
localizes in discrete nuclear domains distinct from
nucleoli. We therefore characterized APH-2 subcellular
localization, in order to decipher the determinants of such
localization and to correlate it or not with APH-2 func-
tions. We first identify APH-2-containing nuclear domains
as PML nuclear bodies (PML-NB). PML-NB are modula-
tors of a number of cellular processes ranging from tran-
scription regulation to cell proliferation and death. We
show that both an in silico-identified nuclear localization
signal and the carboxy-terminal LXXLL motif contribute
to APH-2 targeting to PML-NB. Covalent modification of
APH-2 by SUMO-1 and non-covalent interaction between
APH-2 and SUMO-1-modified cellular partners have also
been investigated as mechanisms of APH-2 targeting to
PML-NB. Our results further demonstrate that APH-2
association with PML-NB is critical for its ability to inhibit
viral transcription. This association also leads to a striking
decrease in APH-2 stability, suggesting that APH-2 might
be active but also targeted to degradation in PML-NB.
Finally, we show that APH-2 localization in PML-NB
leads to PML-NB clustering and correlates with a decrease
in cell proliferation. Altogether, our study sheds new light
on the links between the subcellular localization of APH-2
and its cellular functions.
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